Atogepant
Back to search| Scientific Name: | Atogepant |
| Brand Name: | Qulipta |
| Company Owner: | Not Available |
| Mechanism Of Action | The currently accepted theory of migraine pathophysiology considers dysfunction of the central nervous system, in particular the trigeminal ganglion, to be the root cause behind the condition. |
| Description of the Drug: | Atogepant is an oral CGRP antagonist used for the preventative therapy of episodic migraine headaches. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB16098
